Contents

Search


glial fibrillary acidic protein; GFAP (GFAP)

Classification: - class-3 intermediate filament protein Function: - inhibits neuronal sprouting - interacts with SYNM (putative) - isoform 3 interacts with PSEN1 (via N-terminus) Structure: - belongs to the intermediate filament family Compartment: - cytoplasm - associated with intermediate filaments Alternative splicing: - named isoforms=3; - isoforms differ in the C-terminal region Expression: - expressed in cells lacking fibronectin - cells of astroglial lineage Pathology: - defects in GFAP are a cause of Alexander disease Laboratory: - GFAP in blood FDA-approved to evaluate mild traumatic brain injury (concussion) in adults - assessment of need for CT of brain [6] Note: - during the development of the central nervous system, distinguishes astrocytes from other glial cells

Interactions

molecular events

Related

GFAP gene mutation glial fibrillary acidic protein (GFAP) Ag in tissue glial fibrillary acidic protein (GFAP) in blood/plasma/serum

General

intermediate filament protein phosphoprotein

Properties

SIZE: entity length = 432 aa MW = 50 kD COMPARTMENT: cytoplasm CELL: neuroglia MOTIF: Head {1-72} Rod {73-377} MOTIF: Coil 1A {73-104} Linker 1 {105-115} Thr phosphorylation site {T110} Coil 1B {116-214} Linker 12 {215-230} Coil 2A {231-252} Linker 2 {253-256} Coil 2B {257-377} Tail {378-432} MOTIF: Thr phosphorylation site {T383}

Database Correlations

OMIM correlations MORBIDMAP 137780 UniProt P14136 PFAM correlations Entrez Gene 2670 Kegg hsa:2670

References

  1. UniProt :accession P14136
  2. Human intermediate Filament mutation Database http://www.interfil.org
  3. GeneReviews https://www.genecards.org/cgi-bin/carddisp.pl?gene=GFAP
  4. Wikipedia; Note: GFAP entry http://en.wikipedia.org/wiki/Glial_fibrillary_acidic_protein
  5. Entrez Gene :accession 2670
  6. Brooks M FDA Clears First Blood Test to Aid in Concussion Diagnosis. Medscape - Feb 14, 2018. https://www.medscape.com/viewarticle/892683 - FDA News Release. Feb 14, 2018 FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm596531.htm